Sepsis Therapeutics Market to Reach $6.2 Billion by 2028 - Powered by Increasing Research and Development Programs on Immunometabolism - Exclusive Report by Vantage Market Research

WASHINGTON, Jan. 28, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research’s recent analysis of the global sepsis therapeutics market finds that rising incidence of sepsis globally is accelerating market growth. The market is primarily driven by increasing research and development programs on immunometabolism, the total global sepsis therapeutics market is estimated to reach USD 6.2 Billion by 2028, up from USD 3.5 Billion in 2021, at a Compound Annual Growth Rate (CAGR) of 7.3%.

Furthermore, the increasing inventers in Research and Development (R&D) sector by governments and major players, to augment the growth of the global sepsis therapeutics market, states Vantage Market Research, in a report, titled “Sepsis Therapeutics Market by Drug Class (Aminoglycosides, Cephalosporin, Glycopeptide Antibiotics, Other Drug Classes), by Route of Administration (Intravenous, Oral), by Region (North America, Latin America, Europe, Asia Pacific) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)”.

Click Here To Access The Free Sample Report @

(The Free Sample Of This Report Is Readily Available On Request).

Our Free Sample Reports Includes:

  • In-depth Industry Analysis, Introduction, Overview, and COVID-19 Pandemic Outbreak.
  • Impact Analysis 170+ Pages Research Report (Including latest research)
  • Provide chapter-wise guidance on request 2021 Updated Regional Analysis with Graphical Representation of Trends, Size, & Share, Includes Updated List of figures and tables.
  • Updated Report Includes Major Market Players with their Sales Volume, Business Strategy and Revenue Analysis by using Vantage Market Research methodology.

(Please note that the sample of this report has been updated to include the COVID-19 impact study prior to delivery.)

List of Prominent Players in the Sepsis Therapeutics Market:

  • F. Hoffmann-La Roche Ltd
  • Pfizer Inc.
  • Glaxo Smith Kline Inc
  • Mylan N.V.
  • Allergan, Inc.

Market Dynamics:

Rising Incidence of Sepsis Globally to Fuel Global Sepsis Therapeutics Market

Since past few years, the population across the globe is increasing explosively. Thus, along with increasing population the disease prevalence is also increasing. Consequently, the number of people suffering from sepsis is increasing further boosting the demand for sepsis therapeutics. According to World Health Organization (WHO), the sepsis kills 11 million people each year, many of them children. Sepsis is cause of 1 in 5 deaths worldwide. As per study of WHO, almost half of the 49 million cases of sepsis each year occur among children, resulting in 2.9 million deaths. This could be prevented through early diagnosis and appropriate clinical management. Thus, it is expected to further propel the demand for sepsis therapeutics, in turn, propelling the market growth over the forecast period.

Increasing Research and Development Programs on Immunometabolism and Rising Investments to Stimulate the Market Growth

The prevalence of sepsis across the globe is increasing at its unprecedented level. This is increasing the burden on Research and Development (R&D) sector as well as government. Thus, to tackle this prevalence; governments as well as several major players in the market are investing their money heavily in R&D sector. Thus, propelling the market growth over the forecast period. Key players are adopting collaboration strategies in order to identify/develop novel drugs for the treatment of sepsis. For instance, Asahi Kasei Corporation is planning to launch ART-123 by 2021 for the treatment of sepsis.

Purchase This Premium Report Now @

Benefits of Purchasing Sepsis Therapeutics Market Reports:

  • Customer Satisfaction: Our team of experts assists you with all your research needs and optimizes your reports.
  • Analyst Support: Before or after purchasing the report, ask a professional analyst to address your questions.
  • Assured Quality: Focuses on accuracy and quality of reports.
  • Incomparable Skills: Analysts provide in-depth insights into reports.

COVID-19 Impact Analysis:

Outbreak of COVID-19 have hampered several sectors. Owing to COVID-19, several countries declared lockdown with strict regulations. As a consequence, people were stuck at their places. However, healthcare sector is not much affected, sepsis therapeutics market witnessed a dent on the market growth. Owing to the fear of COVID-19 among the global population, only the people suffering from severe sepsis were taking the risk to visit hospitals, and clinics, or other services. Thus, hampered the sepsis therapeutics market growth. However, things will improve in the second half of 2022 as more supplies will come online. The impact of COVID-19 on the market demand is considered while estimating the current and forecast market size and growth trends of the market for all the regions and countries based on the following data points:

  1. Impact Assessment of COVID-19 Pandemic
    1. North America
    2. Europe
    3. Asia Pacific
    4. Latin America
    5. Middle East & Africa
  2. Quarterly Market Revenue Forecast by Asia Pacific 2020 & 2021
  3. Key Strategies Undertaken by Companies to Tackle COVID-19
  4. Long Term Dynamics
  5. Short Term Dynamics

The Report on Sepsis Therapeutics Market highlights:

  • Assessment of the market
  • Premium Insights
  • Competitive Landscape
  • COVID Impact Analysis
  • Historic Data, Estimates and Forecast
  • Company Profiles
  • Global and Regional Dynamics

Read Full Research Report @

Regional Analysis:

North America Dominates the Global Sepsis Therapeutics Market

North America has dominated the global sepsis therapeutics market in 2021 and is likely to continue the same trend during the forecast period. The market growth is attributed to high prevalence and rise in incidence of sepsis in the U.S. and Canada. Also, presence of major players in the region is also expected to support the regional growth of the market.

Asia Pacific is likely to witness fastest growth in the sepsis therapeutics market during the forecast period. This is attributable to the improving healthcare infrastructure in economies like the India, and China in the region. Furthermore, presence of one of the most populated countries in the world offers a huge base population which is likely to boost the sepsis therapeutics market growth in the region.

Recent Developments:

August, 2021: Asahi Kasei Corporation is planning to launch ART-123 by 2021 for the treatment of sepsis.

August 2019: Pfizer, Inc. partnered with GlaxoSmithKline plc to form a joint venture to create the world’s largest over-the-counter (OTC) business.

Key questions answered in the report:

  • Which regional market will show the highest and rapid growth?
  • Which are the top five players of the Sepsis Therapeutics Market?
  • How will the Sepsis Therapeutics Market change in the upcoming six years?
  • Which application and product will take a lion’s share of the Sepsis Therapeutics Market?
  • What is the Sepsis Therapeutics market drivers and restrictions?
  • What will be the CAGR and size of the Sepsis Therapeutics Market throughout the forecast period?

Speak To Analyst:

This market titled “Sepsis Therapeutics Market” will cover exclusive information in terms of Regional Analysis, Forecast, and Quantitative Data – Units, Key Market Trends, and various others as mentioned below:

Report AttributeDetails
Market Size in 2021USD 3.5 Billion
Projected Market Size in 2028USD 6.2 Billion
CAGR Growth RateCAGR of 7.3% from 2022–2028
Base Year2021
Historic Years2016 – 2020
Forecast Years2022 – 2028
Segments CoveredDrug Class: - Aminoglycosides, Cephalosporin, Glycopeptide Antibiotics, Other Drug Classes

Route of Administration: - Intravenous, Oral
Quantitative Data - UnitsRevenue in USD Million/Billion and CAGR from 2022 to 2028
Regions CoveredNorth America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Countries CoveredU.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Report CoverageMarket growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.

Customization of the Report:

The report can be customized as per client needs or requirements. For any queries, you can contact us on or +1 (202) 380-9727. Our sales executives will be happy to understand your needs and provide you with the most suitable reports.

Download Free Sample Report Now @

Browse More Related Report:

About Vantage Market Research:

We, at Vantage Market Research, provide quantified B2B high quality research on more than 20,000 emerging markets, in turn, helping our clients map out constellation of opportunities for their businesses. We, as a competitive intelligence market research and consulting firm provide end to end solutions to our client enterprises to meet their crucial business objectives. Our clientele base spans across 70% of Global Fortune 500 companies. The company provides high quality data and market research reports. The company serves various enterprises and clients in a wide variety of industries. The company offers detailed reports on multiple industries including Chemical Materials and Energy, Food and Beverages, Healthcare Technology, etc. The company’s experienced team of Analysts, Researchers, and Consultants use proprietary data sources and numerous statistical tools and techniques to gather and analyse information.

Follow Us on LinkedIn:

Follow Us on Twitter:

Contact us

Eric Kunz

6218 Georgia Avenue NW Ste 1 - 564

Washington DC 20011-5125

United States Tel: +1 202 380 9727



Latest Vantage Market Research Press Releases @

Latest Vantage Market Research Blog @